Sunmax Biotechnology Co., Ltd. (4728)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
387. 50
+4
+1.043%
NT$
- Market Cap
- P/E Ratio
25% Div Yield
4,042 Volume
- Eps
NT$ 383.5
Previous Close Want to track 4728 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sunmax Biotechnology Co., Ltd. (4728) Statistics
Valuation metrics
Market Cap -
Enterprise value 20.15B
Trailing P/E (ttm) 29.27
Forward P/E -
PEG ratio -78.09
Price/Sales (ttm) 10.4
Price/Book (mrq) 17.86
Enterprise Value/Revenue 9.9
Enterprise Value/EBITDA 16.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.77K
Average volume (90 days) 5.24K
Price summary
52-Week low 350
52-Week high 431.5
Beta -
50-Day moving average 380.93
200-Day moving average 385.55
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 23.7
Trailing annual dividend yield 0.0609%
5-Year annual dividend yield -
Payout ratio 0.87
Dividend Date 5 May 2026
Ex-Dividend Date 31 Mar 2026
Last split factor 541:500
Last split Date 7 May 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.36%
Operating margin 0.57%
Operational effectiveness
Return on assets 0.3%
Return on equity 0.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 37.4
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 13.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 21.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 1.34%
Book value per share (mrq) 21.78
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
